Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Not yet recruiting1
Active, not recruiting1
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

not_yet_recruiting125%
active_not_recruiting125%
terminated125%
completed125%

Recent Activity

1 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)

NCT07032844
active_not_recruitingnot_applicable

Food Delivery, Remote Monitoring, and Coaching-Enhanced Education for Optimized Diabetes Management (FREEDOM)

NCT05288452
completednot_applicable

Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy

NCT05064787
terminatednot_applicable

Quality of Life of Adults With Diffuse Large B-cell Lymphoma Treated With Tisagenlecleucel

NCT05199961

Clinical Trials (4)

Showing 4 of 4 trials
NCT07032844Not Applicable

Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)

Not Yet Recruiting
NCT05288452Not Applicable

Food Delivery, Remote Monitoring, and Coaching-Enhanced Education for Optimized Diabetes Management (FREEDOM)

Active Not Recruiting
NCT05064787Not Applicable

Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy

Completed
NCT05199961Not Applicable

Quality of Life of Adults With Diffuse Large B-cell Lymphoma Treated With Tisagenlecleucel

Terminated

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4